|
Hyperbaric oxygen therapy for the treatment of idiopathic sudden sensorineural hearing loss |
Rodríguez B, Rey-Ares L, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Bardach A, Ciapponi A, López A |
|
|
Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Rodríguez B, Rey-Ares L, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Bardach A, Ciapponi A, López A. Hyperbaric oxygen therapy for the treatment of idiopathic sudden sensorineural hearing loss. Buenos Aires: Institute for Clinical Effectiveness and Health Policy (IECS). Documentos de Evaluación de Tecnologías Sanitarias, Informe de Respuesta Rápida N° 470. 2016 Authors' conclusions Low quality evidence suggests that hyperbaric oxygen therapy in association with drug therapy could have a small benefit of questionable clinical relevance in improving hearing threshold of patients with idiopathic sudden sensorineural hearing loss. In regards to second line treatment, hyperbaric oxygen therapy has shown to have a similar effect to the administration of intratympanic glucocorticoids.
Most of clinical practice guidelines do not recommend its routine use. Most of consulted health sponsors of Latin America, Europe and the United States do not provide coverage.
Final publication URL www.iecs.org.ar Indexing Status Subject indexing assigned by CRD MeSH Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; Hyperbaric Oxygenation Language Published Spanish Country of organisation Argentina English summary An English language summary is available. Address for correspondence Institute for Clinical Effectiveness and Health Policy, Viamonte 2146 - 3 Piso, C1056ABH Ciudad de Buenos Aires, Argentina Tel: +54 11 49 66 00 82 Fax:+54 11 49 53 40 58 Email: info@iecs.org.ar AccessionNumber 32016000917 Date abstract record published 03/08/2016 |
|
|
|